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after oral intake. No adverse effects have been found in oral 
fertility and developmental toxicity studies, nor are there 
any indications from in vivo studies for an immunotoxic or 
neurotoxic effect. SAS is neither mutagenic nor genotoxic 
in vivo. In intact cells, a direct interaction of unlabelled 
and unmodified SAS with DNA was never found. Differ-
ences in the magnitude of biological responses between 
pyrogenic and precipitated silica described in some in vitro 
studies with murine macrophages at exaggerated exposure 
levels seem to be related to interactions with cell culture 
proteins and cell membranes. The in vivo studies do not 
indicate that there is a toxicologically relevant difference 
between SAS products after oral exposure. It is noted that 
any silicon dioxide product not meeting established speci-
fications, and/or produced to provide new functionality in 
food, requires its own specific safety and risk assessment.
Keywords Synthetic amorphous silica · SAS · Silicon 
dioxide · E 551 · Food safety · Nanostructured
Introduction
Synthetic amorphous silica (SAS), also known as synthetic 
amorphous silicon dioxide, has been used as a direct food 
additive for decades. Both the Joint FAO/WHO Expert 
Committee on Food Additives (JECFA) and the EU Sci-
entific Committee on Food (SCF, now EFSA) have pre-
viously evaluated silicon dioxide as a food additive (E 
551, INS 551) and established an acceptable daily intake 
(ADI) “not specified” which generally refers to substances 
of very low toxicity. The more recent designation of SAS 
as a nanostructured material has, however, raised con-
cerns with regard to its safety as a food additive and has 
prompted several new investigations as well as safety and 
Abstract 
Key messages 
• Particle sizes of E 551 products are in the microme‑
tre range. The typical external diameters of the con‑
stituent particles (aggregates) are greater than 100 
nm.
• E 551 does not break down under acidic conditions 
such as in the stomach, but may release dissolved 
silica in environments with higher pH such as the 
intestinal tract.
• E 551 is one of the toxicologically most intensively 
studied substances and has not shown any relevant 
systemic or local toxicity after oral exposure.
Abstract Synthetic amorphous silica (SAS) meeting the 
specifications for use as a food additive (E 551) is and has 
always been produced by the same two production meth-
ods: the thermal and the wet processes, resulting in E 551 
products consisting of particles typically in the micrometre 
size range. The constituent particles (aggregates) are typi-
cally larger than 100 nm and do not contain discernible pri-
mary particles. Particle sizes above 100 nm are necessary 
for E 551 to fulfil its technical function as spacer between 
food particles, thus avoiding the caking of food particles. 
Based on an in-depth review of the available toxicological 
information and intake data, it is concluded that the SAS 
products specified for use as food additive E 551 do not 
cause adverse effects in oral repeated-dose studies includ-
ing doses that exceed current OECD guideline recommen-
dations. In particular, there is no evidence for liver toxicity 
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risk assessments by various research groups. This article 
has therefore been written to specifically address these 
new safety concerns, including the possibility of low-dose 
effects, toxicity of potentially released nanoparticles, liver 
toxicity, and immunotoxicity.
Background: SAS as a direct food additive (E 551, 
INS 551)
Specific purity criteria are defined for the use of SAS as 
a food additive. In the European Union (EU), the specific 
purity criteria are defined in Commission Regulation (EU) 
No 231/2012. SAS meeting these criteria is permitted 
under the name of “Silicon dioxide” or “E 551” as direct 
food additive in accordance with Annex II and Annex III to 
Regulation (EC) No. 1333/2008 (as amended) as an anti-
caking agent and a carrier. The specific criteria in Commis-
sion Regulation (EU) No. 231/2012 also contain the two 
production methods with which SAS is made: the thermal 
process and the wet process. These processes result in solid 
SAS products of identical chemical composition either as 
anhydrous products (pyrogenic SAS, produced by the ther-
mal route) or as hydrated products (precipitated silica, sil-
ica gel, or hydrous silica; all produced by the wet route). 
An overview of SAS products which are used as a food 
additive (E 551) is presented in Table 1.
SAS as used as a food additive (E 551, INS 551) is mar-
keted as a white fluffy powder or as granules which, in the 
case of hydrated silica, may contain surface- or pore-bound 
water. Importantly, E 551 is not marketed as a suspension 
of stabilised nanoparticles (colloidal silica). Since the begin-
ning of its commercialisation in the 1950s (ECETOC 2006), 
SAS is produced by the same two manufacturing processes, 
i.e. the thermal process and the wet process. These two pro-
duction methods have been described earlier (EC 2007). 
The resulting products are chemically identical; prod-
ucts made by the wet process may contain sodium salts as 
impurities resulting from the manufacturing process based 
on sodium silicates. E 551 is placed on the market in solid 
form only and should therefore not be confused with sta-
bilised suspensions of silica nanoparticles (often referred to 
as colloidal silica). The latter are manufactured by different 
processes, e.g. the Stöber method, and do not meet the EU 
specifications for E 551. These colloidal silica suspensions 
are not regulated as direct food additive (E 551) in the EU, 
but may be used as processing aid in EU countries under 
national legislation and be marketed as food grade.
E 551 is not produced in a nano- and non-nanoform, nor 
does it exist in a nano- and non-nanoform. E 551 is not engi-
neered to have novel properties, and the particle size distribu-
tions of aggregates and agglomerates of today’s products are 
in fact identical to those produced in earlier decade. Since 
the technical function of E 551 is to act as a spacer between 
food components in order for them to remain in a free state, 
nanosized particles are actually not desired because they 
are too small to enable this effect. The spacer function can 
only be achieved by the silica aggregates and agglomerates 
having size ranges which are typically greater than 100 nm 
(it is noted that there are studies published, where almost 
spherical corn starch host particles with a smooth surface 
were used and where adsorbate diameters of anti-caking 
agents down to 40–50 nm are mentioned (Kurfeβ et al. 2005; 
Müller et al. 2008; Ruppel et al. 2009). Such powders do, 
however, not represent the typical host powder where larger 
spacers are required to fill cavities). Regulatory aspects relat-
ing to the EU food sector have recently been summarised 
and are therefore not re-iterated here (Amenta et al. 2015).
E 551 particle morphology and size
E 551 is produced as fluffy fine powder or granules in the 
micrometre size range. Figure 1 (left) shows a ca. 20–30 
micrometre granule as typically contained in products 
delivered to the customer. Powders and granules consist of 
Table 1  Overview on synthetic amorphous silica products used as a food additive (E 551)
a  JRC EU Joint Research Centre
Product EU name  
(Reg. 231/2012)
EINECS no CAS no., generic CAS no., specific Chemical abstracts 
index name
JRCa name









Silica gel, hydrous 
silica
231-545-4 7631-86-9 112926-00-8 Synthetic amorphous 
silica, gel; crystal-
line-free
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agglomerated aggregates (see Fig. 1, middle). Agglomer-
ates can be separated into aggregates (see Fig. 1, right) by 
applying high energy or shear force techniques such as pro-
longed ultrasonication or mixing.
These aggregates are the smallest discrete entities in E 
551; they are three-dimensional units with a high degree of 
branching. The typical external size of SAS aggregates is 
greater than 100 nm; separation of aggregates into “primary 
particles” is impossible (Dünisch 2005; ECETOC 2006; 
Gray and Muranko 2006; Ma-Hock et al. 2007; Maier et al. 
2006). The aggregates can therefore be designated as the 
constituent particles of E 551. Primary particles—accord-
ing to the ISO definition “the original source particles of 
agglomerates or aggregates or mixtures of the two”—are 
not discernible anymore in E 551 after completion of the 
synthesis process. All primary particles have been fused 
together to form the three-dimensional aggregates. No 
inner boundaries are visible within SAS aggregates (Albers 
et al. 2015), see Fig. 2.
Because there are no discernible “primary particles” 
anymore in the E 551 product, it is impossible to determine 
their size or size distribution. With regard to aggregate 
sizes and aggregate size distributions, several techniques 
are usually necessary for a reliable volume- or mass-based 
size determination. Generally, external aggregate sizes are 
greater than 100 nm (data on file), but sample preparation 
methods and the analytical method have a profound influ-
ence on the results (Barahona et al. 2016). If not used in 
combination with other techniques, 2-dimensional ultras-
copy methods (scanning electron microscopy, SEM, or 
transmission electron microscopy, TEM), in particular, are 
not suitable to determine SAS aggregate size distributions. 
In the case of branched aggregates, such as SAS, 2-dimen-
sional SEM and TEM generate so-called equivalent diam-
eters and an apparent (i.e. not a real) property of SAS, 
namely that it would contain small isolated particles in the 
nanosize range. The European Commission JRC report on 
the requirements on measurements for the implementa-
tion of the European Commission definition of the term 
“nanomaterial” reads (page 22 of the report) (Linsinger 
et al. 2012): “…It has been suggested that electron micros-
copy (EM) [in particular, transmission electron microscopy 
Fig. 1  SEM images of pyrogenic silica granule, agglomerate, and aggregate (©Evonik Resource Efficiency GmbH)
Fig. 2  TEM images of part of a pyrogenic silica aggregate (left) and enlarged view of inner structures at the nanometre scale (middle, right) 
(©Evonik Resource Efficiency GmbH)
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(TEM)] provides the most accurate particle size values. 
This, however, relies on the assumption that a projected 
area equivalent size is the ‘true size’. Unfortunately, this 
size is deduced from a 2D image and is independent of 
the thickness of the particle in the third dimension. A sec-
ond disadvantage is that it does not correspond to com-
mon understanding: the area equivalent size of a highly 
branched particle may be very small, whereas it can extend 
widely, reaching a large external dimension”. It is further-
more known that the preparation of representative samples 
is a major source of uncertainty, and that the automated 
counting of digitally processed TEM and SEM images gen-
erates artificially high numbers of particles in the nanosize 
range when agglomerates are present. Reports based solely 
on TEM/SEM methodology and claiming that 100 % of E 
551 would be in the nanosize range are therefore mislead-
ing (Agir pour l’environnement 2016). Currently, there 
are no reliable standardised analytical methods available 
to characterise the number weighted particle size distribu-
tion of SAS in the nanosize range below 100 nm. Efforts to 
establish such distributions suffer from the assumption of a 
spherical particle shape, see, for example, (Barahona et al. 
2016; Contado et al. 2016), which is not correct in the case 
of E 551 as the E 551 aggregate is not a sphere.
Exposure and intake estimates
Information on relevant food categories and use lev-
els of E 551 were recently collected by members of the 
Association of Synthetic Amorphous Silica Producers 
(ASASP) from customers and from food associations. 
This was the only way for the raw material suppliers to 
gain this information. According to the survey, the uses 
covered were all direct uses and carry-over into foods. 
The collected data were used to generate intake estimates 
with the Comprehensive European Dietary Exposure 
Model (CEDEM) (Tennant 2016) and resulted in popu-
lation average intake estimates of silicon dioxide from 
its use as a food additive (E 551) ranging between 0.28 
and 4.53 mg E 551/kg bw/day. The highest intake esti-
mate was at 12.7 mg/kg bw/day for children in Bulgaria 
which is likely to be an overestimate because it assumes 
100 % occurrence of E 551 in all food categories. Earlier, 
a daily exposure of 9.4 mg/kg bw/day was estimated for 
the Dutch population based on expert judgement of con-
sumption frequencies and amounts (Dekkers et al. 2011).
For the total dietary intake of E 551, not only the 
amount of E 551 in food has to be estimated, but also 
potential intake from other sources. In addition to its use 
as a food additive, E 551 is also used in cosmetics (e.g. 
as abrasion additive in toothpastes), in pharmaceuticals 
(e.g. as free-flow additive, carrier, or retardant agent and 
as tableting aid), and in dietary supplements (e.g. as dis-
persive medium for vitamins). Some naturally occurring 
foods, particularly of plant origin, contain high amounts 
of biogenic silicon dioxide, amongst them cereals, par-
ticularly oats and barley, wheat flour, rice, and, espe-
cially, beer (see, for example, EFSA 2009; Jugdaohsingh 
2007; Powell et al. 2005). The difficulty in analysing food 
matrices for E 551 particles and to differentiate these 
from the high natural silicon and silicon dioxide (silica) 
content of many foods make a direct measurement diffi-
cult. Usually dissolved silicon is extracted and measured, 
but there are currently no validated routine methods for 
the quantitative determination of silicon dioxide particles 
in food (Singh et al. 2014). Current laboratory methods 
for silica particle analysis are only validated for the anal-
ysis in relatively simple and defined matrices and often 
have a low sensitivity in the size range below 200 nm and 
a low reproducibility.
In food supplements, silica is added up to a level of 
700 mg silicon/day (EFSA 2009). Estimates on the intake 
of E 551 contained in pharmaceutical formulations are not 
available. Very low levels (<0.2 %) are required when used 
as a glidant for tablets, the most common medicinal appli-
cation. Toothpaste may, however, contain relatively high 
amounts of E 551, which in part may be swallowed.
An overview of intakes from different sources is pro-
vided in Table 2.
Bioavailability after oral intake
Due to the changing and complex conditions in the gastro-
intestinal tract, including different pH environments, the 
influence of food matrices, microflora, mucus, and peri-
staltic movements, it is difficult to fully predict the fate of 
E 551 particles after oral ingestion. Due to analytical dif-
ficulties mainly because of high environmental background 
silica levels, no studies are available in which unlabelled 
silica particles were quantitatively analysed in body fluids 
and organs after oral exposure. Results of in vitro digestion 
studies (Maier et al. 2013; Peters et al. 2012; Sakai-Kato 
et al. 2014) have shown a resistance of silica agglomerates 
and aggregates to break down under conditions of low pH 
such as in the stomach. Dissolution may increase in the 
more alkaline pH environments of the small intestine and 
in the colon, and values of up to 20 wt% have been reported 
for the dissolution in the intestinal content (van der Zande 
et al. 2014). These findings are in agreement with biodura-
bility tests performed with SAS in Caco-2 medium by the 
European Joint Research Centre (JRC 2013). A fraction 
of E 551 may therefore be taken up in form of orthosilicic 
acid by the intestinal tract. If absorbed, particles are usually 
sequestered in Peyer’s patch macrophages, and those that 
2889Arch Toxicol (2016) 90:2885–2916 
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escape sequestration are transported by lymph rather than 
by portal blood. It has been suggested that the nanosized 
fraction of ingested particles could directly pass through 
regular epithelial cells to underlying dendritic cells (Howe 
et al. 2014), but there are no studies demonstrating this for 
SAS. Given the high exposure to natural silica in foods, 
and the lack of any signs of an immunotoxic potential of 
SAS in repeated-dose animal studies, an adverse effect by 
this mechanism is unlikely.
In an oral 28-d study in rats with food-grade precipi-
tated silica, mesenteric lymph nodes, liver, and kidney were 
investigated by electron microscopy for silica particles. 
Occasionally, cells of the mesenteric lymph nodes, liver, 
and kidneys of all animals of the untreated group and of 
the amorphous silica-treated group showed electron dense 
structures. These electron dense structures were found in 
vacuoles in the cytoplasm and were characterised as “irreg-
ular homogenous to fine granular material”. The granular 
structures measured only few nanometres, but did not show 
the shape or appearance of amorphous silica. These results 
show the presence of particulate matter in the nanosize 
range in ALL animals, i.e. including those NOT exposed 
to precipitated silica (CEFIC 2011). Silica particles could 
also not be found in the livers of rats exposed for 28 or 
84 days to food-grade pyrogenic silica (van der Zande et al. 
2014). Silicon (Si) concentrations were not increased in the 
investigated organs (liver, kidney, testis, brain) even after 
high-dose exposure for up to 84 days. An increase in Si lev-
els was only found in the spleen of rats exposed to an oral 
dose of 2500 mg/kg bw/day (for 84 days) (van der Zande 
et al. 2014), a dose level that exceeds the current recom-
mendations in OECD guidelines by a factor of 2.5. If taken 
up by cells, SAS particles are usually located in vesicles 
and endocytic compartments, and also along actin fibres 
and nuclear invaginations (Tarantini et al. 2015b); they 
are, however, never found in the nucleus. Reports to the 
contrary always refer to dye-labelled or otherwise modi-
fied silicon dioxide. Such materials, however, are not per-
mitted for use as a food additive. These results cannot be 
read across to E 551, and it is not appropriate to conclude 
from them that unlabelled and unmodified silica particles 
would translocate in the cell nucleus. Several researchers 
have also relied on dye-labelled or modified silicon dioxide 
particles to trace the fate of silica in the body; these parti-
cles are, however, different from E 551 with regard to their 
physico-chemical properties (in particular different particle 
sizes, surface area, porosities, and stabilities), and the influ-
ence of dyes on the biodistribution, stability, and toxicity 
of silica particles is not sufficiently studied. Data generated 
from studies with these engineered materials cannot there-
fore be read across to E 551. Often results from intrave-
nous studies are employed to derive biodistribution of SAS 
after oral exposure, e.g. by van Kesteren et al. (2015). Pat-
terns of distribution can, however, be expected to be dif-
ferent, because of the different mode of application (local 
bolus directly into the intravenous compartment versus a 
slow absorption pattern by the large area of the intestinal 
tract after oral exposure), resulting also in different surface 
modifications (different corona formation) according to 
the route of entry (Inlivetox 2012). As already suggested 
Table 2  Silicon and Silicon dioxide (silica particle) intakes from different sources
a Particle size range 1–200 nm
b (SCCS 2015): daily intake, toothpaste = 138 mg or 2.16 mg/kg bw
Source Daily intake References
Silicon (Si) mg/day mg/kg bw/day
Food (naturally and from additives), 
Western population
20–50 0.3–0.8 EFSA (2004), Jugdaohsingh (2007) and 
Jurkić et al. (2013)
Food (mainly plant based) 140–204 Cited in Jugdaohsingh (2007)
Food (BE) 18.6 ± 8.5 Robberecht et al. (2009)
Beer (1 litre) 6.4–56.5 Casey and Bamforth (2010)
Dietary supplements 1–75, up to 700 0.017–1.5, up to 12 EFSA (2004, 2009)
Silica (SiO2)




Dekkers et al. (2011)
E 551 in food 0.28–4.53 (FCRA 2016)
Dietary supplements up to 1500 up to 25 EFSA (2009)
Mixed silicate particles in food 35 (0–254) Lomer et al. (2004)
Toothpaste containing 30 % SAS 41 0.65 Using intake data from (SCCS 2015)b
E 551 in medicines 0.2 Based on two oral tablets/day à 0.5 g with 
0.02 % E 551
2890 Arch Toxicol (2016) 90:2885–2916
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earlier (NANOGENOTOX 2013), it can be concluded that 
the systemic availability of silica particles is low after oral 
exposure. The dissolved form might be absorbed by the 
intestinal tract.
Toxicity
Core areas defined by EFSA for the assessment of food 
additive toxicity include genotoxicity, subchronic and 
chronic toxicity, carcinogenicity, and reproductive and 
developmental toxicity as well as neurotoxicity, immuno-
toxicity, and endocrine-mediated effects (EFSA 2012). 
These areas are therefore addressed in the following 
sections.
Genotoxicity
Food-grade silicon dioxide was neither mutagenic nor 
genotoxic in standard in vitro test systems (Ames, HPRT, 
mouse lymphoma, and chromosome aberration studies) 
(CEFIC 2012a, b; ECETOC 2006). In vitro micronuclei 
tests were negative in human lymphocytes and BEAS2B 
cells, inconclusive in undifferentiated Caco-2 cells, and 
positive in some lung-derived cells at cytotoxic concen-
trations (NANOGENOTOX 2013; Tarantini et al. 2015b; 
Tavares et al. 2014; Zijno et al. 2016). The findings of 
in vitro indicator tests were negative for pyrogenic and 
hydrated silica under non-cytotoxic conditions (cf. Table 3 
for details).
Standard oral in vivo genotoxicity tests were all nega-
tive (bone marrow micronucleus test, chromosome aberra-
tion test (NANOGENOTOX 2013; Tarantini et al. 2015a). 
Also, the pig-a test and the in vivo comet assay were 
negative (Guichard et al. 2015; NANOGENOTOX 2013; 
NANoREG 2015; Tarantini et al. 2015a). The organs/tis-
sues studied in the comet assay were liver, kidney, blood, 
bone marrow, stomach, duodenum, and colon. It is noted 
that “significant increased DNA damage” in the comet 
assay was reported in bone marrow and spleen of male 
rats, and in ovary cells, all without a dose–response rela-
tionship, after daily gavage exposure for 45 days within 
a 90-day study with pyrogenic food-grade SAS. The low 
doses employed (maximum dose 50 mg/kg bw/day) which 
are below the normal range of rat diet silicon content (see, 
for example, Jugdaohsingh et al. 2015; van der Zande 
et al. 2014), the lack of a dose–response, and the known 
variability in comet results indicate that these observations 
are within the normal physiological range. No effects were 
found in testes, liver, kidney, intestines, and colon (Fes-
sard et al. 2016; NANoREG 2015). Additionally, a non 
-standard colon micronucleus test was performed following 
repeated oral administration of precipitated and pyrogenic 
SAS on three consecutive days. No induction of micronu-
clei was found with precipitated SAS, but a slight increase 
in borderline statistical significance was noted in colon 
samples of rats treated with the lowest dose (5 mg/kg bw/
day) of pyrogenic SAS (NANOGENOTOX 2013; Tarantini 
et al. 2015a). The preliminary genotoxicity data from the 
ongoing 90-day study in rats do, however, not show any 
genotoxic effects on the gastrointestinal tract (NANoREG 
2015); in particular, no micronuclei were found in colon 
samples (Fessard et al. 2016) again indicating that the 
observations are within the normal physiological range 
and not substance related. The very low genotoxic poten-
tial is also evidences by studies employing the intravenous 
route, when genotoxicity (micronuclei) was only found at 
doses exceeding the maximum tolerated dose (MTD) level 
(Downs et al. 2012; NANOGENOTOX 2013).
The available genotoxicity studies are summarised in 
Table 3 (in vitro studies) and Table 4 (in vivo studies).
Subchronic and chronic toxicity
The available oral studies include 28-day gavage and feed-
ing studies with pyrogenic silica, a 28-day gavage study 
with precipitated silica (CEFIC 2011; van der Zande et al. 
2014), an old 90-day feeding study with pyrogenic silica 
(ECETOC 2006), and 84- and 90-day feeding studies with 
precipitated silica (ECETOC 2006; van der Zande et al. 
2014). A low-dose 90-day gavage study with pyrogenic sil-
ica (NM-203) is still ongoing (NANoREG 2015). Details 
on the older studies have been summarised in the docu-
ments by the IARC (IARC 1997), the OECD (OECD 
2004), the ECETOC (ECETOC 2006), the EFSA (EFSA 
2004, 2009) and been published within the OECD Pro-
gramme on Nanomaterials.1
An overview of the available oral studies and their main 
results is presented in Table 5. Because colloidal silica is 
chemically identical apart from stabilisers and possibly 
additives, results with colloidal silica are also included in 
the table, although it is not permitted to be used as E 551.
In the 28-day rat studies, NOAELs of 1000 mg/kg bw/
day or above were determined, with no specific target 
organs identified (CEFIC 2011; van der Zande et al. 2014). 
In an extended study according to OECD TG 407 (CEFIC 
2011), the measurements of the spontaneous locomotor 
activity and the functional observational battery showed no 
influence of the treatment up to and including the highest 
1 http://www.oecd.org/chemicalsafety/nanosafety/testing-pro-
gramme-manufactured-nanomaterials.htm, accessed May 27, 2016.
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tested dose of 1000 mg/kg bw/day (it is noted that only 
male animals were used in this study).
Similarly, the NOAELs in the 90-day rat studies were 
also at 1000 mg/kg bw/day or above with no specific tar-
get organs identified (ECETOC 2006; van der Zande et al. 
2014). Only in one single rat study, in which two pyrogenic 
silica products (designated NM-202 and “SAS”) were stud-
ied in parallel, mild liver fibrosis was reported after oral 
exposure to 1000 mg NM-202/kg bw/day, but not after 
dosing SAS at 2500 mg/kg bw/day. In this study (van der 
Zande et al. 2014), the occurrence—but not the severity—
of periportal liver fibrosis was reported to be significantly 
increased (p = 0.021 when compared with the control ani-
mals). Fibrosis is, however, not visible on the histological 
images presented in the publication [Fig. 5, F/G; referred 
to as showing fibrosis by (van der Zande et al. 2014)]. The 
small amount of connective fibrous tissue represents the 
normal anatomical situation of periportal fields where bile 
ducts, arteries, and veins are located within a small amount 
of fibrous tissue. Hence, the histopathological diagno-
sis of periportal fibrosis in this study has to be questioned 
(K. Weber, AnaPath GmbH, personal communication, July 
2016). Liver silicon concentrations, liver enzymes, and bio-
chemical markers were unaffected, and “the number of lym-
phocytic cells and thereby also the number of inflammatory 
granulomatous foci (the average number of cells in each 
of the foci) remained unchanged after 28, and 84-days” 
was unchanged, as evidenced by quantitative histologi-
cal assessment of livers (van der Zande et al. 2014). There 
was therefore no evidence found for Kupffer cell activation 
(which might induce liver re-modelling), or inflammatory 
granuloma formation as a key event for the induction of 
liver fibrosis. Results from in vitro studies show that liver 
cells are not very sensitive towards SAS, and that relevant 
toxicity is only caused when incubated with Kupffer cells 
(Chen et al. 2013). Taken together, the lack of significant 
exposure after oral intake and the absence of inflammation, 
resident or peripheral macrophage stimulation and granu-
loma formation in the liver, clearly demonstrate that there 
is no plausible mechanism for the induction of liver fibrosis 
by oral intake of E 551.
Carcinogenicity
The carcinogenic potential of silica gel (Syloid® 244) was 
investigated in an oral study in B6C3F1 mice and F344 rats 
(20/sex/group/species) after dietary administration at 0, 
1.25, 2.5, and 5 % for at least 21 and 24 months, respec-
tively. These concentrations correspond to dose levels of 
approximately 0, 1800, 3500, and 7000 mg/kg bw/day for 
mice and 0, 625, 1250, and 2500 mg/kg bw/day for rats. 
The administration of silica gel was well tolerated. There 
were no biologically or toxicologically significant changes, 
and silica gel was therefore considered to be devoid of 
toxic or carcinogenic potential (Takizawa et al. 1988).
Reproductive and developmental toxicity
No adverse effects on reproduction or development were 
found in old and limited studies with silica gel as reviewed 
by the EFSA (2004, 2009). In a dominant lethal test per-
formed with silica gel [US-FDA 1974, as cited by ECE-
TOC (2006)], no effects of treatment (up to 5 × 5000 mg/
kg bw, oral) were found on fertility index, total number 
of implantations of corpora lutea, pre-implantation losses, 
and dead implants. Results from several oral repeated-dose 
toxicity studies did not indicate any adverse health effects 
including the highest tested dose levels.
After intravenous dosing of mice with colloidal 70-nm 
silica particles, placental dysfunction, foetal resorption, 
and growth retardation were reported (0.2, 0.4 and 0.8 mg/
mouse on gestational day (GD)16 and GD17) (Yamashita 
et al. 2011). The effects could be prevented by a combined 
treatment with heparin, and the activation of the comple-
ment system was therefore assumed as a potential mecha-
nism. The test material is different from E 551, and it is 
unlikely that after oral exposure, silica particles would be 
present in blood and reproductive organs at similarly high 
levels as achieved by intravenous injection. These find-
ings are therefore not relevant for the assessment of E 551. 
Modern guidelines studies employing the oral route have 
not shown any adverse effects of food-grade silicon dioxide 
on the foetus (see below).
In a recent embryonic stem cell test (EST) performed 
within the EU FP7-funded MARINA project, precipitated 
and pyrogenic silicon dioxide as used in food additives 
(NM-200 and NM-203) was classified as “non-embryo-
toxic” (Farcal et al. 2015). A study reporting inhibition of 
embryonic stem (ES) cell differentiation after exposing 
the D3 murine ES cell line to spherical laboratory-syn-
thesised amorphous silica nanoparticles (Park et al. 2009) 
is not considered relevant, as such material is not used in 
food additives. In vitro studies with human placental mod-
els, performed within the EU FP7 project NanoTest, were 
inconclusive, and, as it seems performed with fluorescent 
dye-labelled material which is different from E 551 (Dusin-
ska and Tran 2015; Poulsen et al. 2015).
Within the Cefic LRI testing programme, precipitated 
synthetic amorphous silica has recently been tested in GLP 
and guideline studies for its potential effects on reproduc-
tion and development. These studies are summarised in the 
following sections.
A GLP oral two-generation reproductive toxicity 
study was recently performed in the Wistar rat according 
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to OECD guideline 416 (Wolterbeek et al. 2015). The 
administration by gavage of precipitated synthetic amor-
phous silica (NM-200, purity 96.5 %) at doses up to 
1000 mg/kg bw/day had no adverse effects on the repro-
ductive performance of rats or on the growth and devel-
opment of the offspring into adulthood for two consecu-
tive generations. The NOAEL was 1000 mg/kg bw/day. 
The mean hydrodynamic diameter of the silica particles 
in the 10 g/L study samples (dispersion in 0.5% aque-
ous methylhydroxypropyl cellulose) varied between 1076 
and 1664 nm and for the 30 g/L study samples between 
876 and 1216 nm, respectively. The measured size of the 
100 g/L study samples appeared to be the smallest (409–
703 nm), but due to the high concentration of the particles 
in the samples, the particles sedimented and aggregated. 
The animals received the test substance during a premat-
ing period of 10 weeks, during mating, gestation and lac-
tation until sacrifice. Dams were allowed to raise one lit-
ter. At the end of the lactation period, pups were weaned 
and selected for the next generation. F0- and F1-dams 
were sacrificed at or shortly after weaning, and F0- and 
F1-males after mating. F1-pups were dosed by gavage at 
the same dose levels as their parents from post-natal day 
21 until sacrifice. Reproductive parameters (including 
oestrus cycle, evaluation, and sperm analysis) and devel-
opmental parameters (including sexual maturation) were 
measured. At sacrifice, reproductive organs and tissues 
were sampled for histopathological analysis. In both gen-
erations, no treatment-related effects were observed on 
body weights, body weight changes, and food consump-
tion. In both generations, no treatment-related effects 
were observed on oestrus cycle parameters of the female 
animals and on sperm parameters of the male animals. In 
both generations, no effects of the test item were observed 
on mating, female fecundity, male- and female fertility, 
and gestation indices. Pre-coital time, duration of ges-
tation, and the incidence of dams with stillborn pups or 
implantation loss were not affected. No test substance-
related adverse effects were observed on the mean number 
of pups delivered, the incidences of live born- and still-
born pups, the number of pups lost during the lactation 
period, the sex ratio, clinical observations, nor necropsy 
findings. In both generations, there were no effects on pup 
weights and pup weight changes. No statistically signifi-
cant differences were found amongst the various groups 
in timing of testes descent, preputial separation, and vagi-
nal opening. There were no gross pathological findings in 
the stillborn pups, pups that died during lactation, and in 
pups necropsied at post-natal day 21. Organ weights of 
pups and of parents of both generations were not affected. 
There were also no gross or histopathological changes in 
the F0- and F1-generation animals.
In a GLP study on rats in compliance with OECD TG 
414, orally administered precipitated silica (NM-200) 
had no adverse effects on development; the NOEL was 
at 1000 mg/kg bw/day, the highest dose tested (Hofmann 
et al. 2015; Schneider et al. 2011). The test substance, 
dispersed in water with 10 % foetal bovine serum, was 
administered at doses of 0, 100, 300, and 1000 mg/kg bw/
day from GD 6 through GD 19 by oral gavage. On GD 20, 
all females were assessed by gross pathology, including 
weight determinations of the uterus and the placentas. The 
corpora lutea were counted, and the number and distribu-
tion of implants (resorptions, live and dead foetuses) were 
determined. The foetuses were removed from the uterus, 
their sex determined, weighed, and investigated for external 
findings. Half of the foetuses of each litter were examined 
for soft tissue findings and the remaining foetuses for skel-
etal (and cartilage) findings.
No differences were found between the treatment groups 
and controls with regard to clinical observations, body 
weights, and food consumption of the dams. No effects 
were observed on number of corpora lutea, implants, pre- 
and post-implantation losses, or number and viability of 
offspring. External, soft tissue and skeletal examination 
showed no test substance-related abnormalities. The No 
Observed Effect Level (NOEL) for maternal and develop-
mental toxicity was therefore derived at 1000 mg/kg bw/
day, the highest dose tested.
The results of this modern guideline study are in line 
with earlier findings in limited prenatal developmental tox-
icity studies performed with silica gel (Syloid® 244) by the 
oral route in rats, mice, hamsters, and rabbits. The NOELs 
for maternal and developmental toxicity in these studies 
were at 1340–1600 mg/kg bw/day, the highest doses tested 
(US-FDA 1973. as cited in ECETOC 2006).
Neurotoxicity, immunotoxicity, 
endocrine‑mediated effects
The available information from repeated-dose, develop-
mental, and reproductive toxicity studies does not indicate 
any adverse effects on the nervous, immune, or endocrine 
systems. Dedicated studies for neurotoxic, immunotoxic, or 
endocrine-mediated effects were therefore not performed. 
A functional observation battery (FOB) was integrated in 
the 28-day repeated-dose toxicity study (CEFIC 2011), 
and lymphoid tissue and immunological parameters were 
investigated in 28- and 84-day studies (van der Zande et al. 
2014). In none of these investigations, was any indication 
of neurological or immunological effects found.
With two food-grade pyrogenic silicon dioxide products 
(NM-203 and SAS), no effects were found on antibody 
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levels in blood (IgG and IgM), or on cytokine levels pro-
duced by proliferating T and B cells, that were isolated 
from spleen and mesenteric lymph nodes. Proliferation 
of the isolated T and B cells and the activity of NK cells 
isolated from spleen were also examined after 28 days 
of exposure, but remained unaffected. Immunotoxicity 
parameters were also studied in vitro and in vivo within 
the 90-day gavage study performed with NM-203 in the 
low-dose range (Di Felice et al. 2016; NANoREG 2015). 
The parameters studied in vitro included inflammatory 
and functional endpoints in the murine macrophage cell 
line RAW264.7, apoptosis/necrosis, cytokine secretion, 
and NO production. No significant effects were found 
in vitro, but an “impaired lymphocyte response to mito-
gen associated with reduced numbers of circulating white 
blood cells, and enhanced inflammatory response by peri-
toneal macrophages” were reported (Maranghi et al. 2016). 
In the absence of any other biochemical changes indicat-
ing inflammatory processes or adverse effects, these find-
ings and the reported statistically significant increase in the 
incidence of intralobular lymphoid infiltration in livers of 
females are not considered to have toxicological relevance. 
Since the silica doses employed in this study are within the 
normal silica content range of usual laboratory rat diets*, it 
is very unlikely that an adverse effect would be caused by 
the doses employed. [*up to 5000 µg Si/g food ((De Jong 
2012), resulting in up to 400 mg Si/kg bw assuming a food 
intake of 20 g/day for a 250 g rat.].
Information from in vitro studies
Many have investigated the in vitro effects of silica particles 
in a wide variety of cell types. While previously cells of the 
respiratory tract were the focus of the studies, more recently 
also cells relevant, or potentially relevant, for the oral expo-
sure route have been investigated. E 551 exerts its function 
as anti-caking agent mainly by covering the surface of host 
powders and thus acting as a spacer, and through its water 
adsorption capacity. Similarly, SAS particles may adsorb to 
cellular surfaces and proteins and may thus affect biologi-
cal membrane structures and integrity. The in vitro results 
vary with the cell type and the extent of direct contact with 
silica particles. Except for red blood cells, macrophages 
were shown to be the most sensitive cell type after in vitro 
exposure to pyrogenic and precipitated silica. Alveolar mac-
rophages were more sensitive than peritoneal macrophages 
(Di Cristo et al. 2016; Farcal et al. 2015; Fruijtier-Pölloth 
2012). This is consistent with the physiological function 
of macrophages to clear particulate matter from the body. 
In vitro studies in cell types with relevance to the oral expo-
sure route are summarised in Table 6.
Discussion
The smallest constituent particles in E 551 are the aggre-
gates, in which no primary particles are discernible. In 
order to exert its technological function as anti-caking 
agent in foods, E 551 must be present in sizes greater than 
100 nm, and nanosized particles are therefore actually not 
desired. The results of aggregate size measurements are 
much influenced by sample preparation, including disper-
sion and dilution methods, and show volume weighted 
external diameters generally greater than 100 nm when 
using several different particle sizing techniques (data on 
file). This is in agreement with analytical results from the 
JRC showing E 551 aggregate sizes of greater than 100 nm 
when measured by dynamic light scattering (DLS) after 
applying ultrasonic dispersion at around 3000 Joule and 
filtering off larger particles (Barahona et al. 2016). Num-
ber weighted particle size distributions are currently not 
measurable with standardised methods, and estimates suf-
fer from the assumption that SAS aggregates are spherical 
particles, which is inaccurate in the case of E 551. From the 
results of a recent study within the EU FP7-funded Nano-
Define project (http://www.nanodefine.eu/) using several 
available particle sizing techniques, it has been concluded 
that “…the determination of the smallest external dimen-
sion remains challenging (if possible at all) for several 
classes of morphology, e.g., for three-dimensional aggre-
gates…” (Babick et al. 2016). In this study, a stabilised sus-
pension of fumed silica particles (colloidal silica) was used, 
which must not to be confused with E 551.
After oral intake, it might be possible that E 551 disinte-
grates during its passage through the intestinal tract. Avail-
able evidence, however, shows that there is no release of 
small particles in the acidic environment of the stomach. 
In more distal parts of the intestines, the more alkaline pH 
environment may cause some dissolution and formation 
of orthosilicic acid. As shown by van der Zande (van der 
Zande et al. 2014), silicon dioxide particles in the nanosize 
range (defined by the study authors to be below 200 nm) 
are found in the colon of non-E 551-exposed animals. The 
finding is also in agreement with biodurability studies per-
formed in Caco-2 medium by the JRC (JRC 2013).
The overall evidence also shows that there is no indi-
cation that oral intake of E 551 may lead to liver toxic-
ity. Studies cited in literature that show liver toxicity after 
amorphous silica exposure either relate to dye-labelled 
material, to biogenic material, or to exposures by the intra-
venous route. Studies with dye-labelled material cannot 
be read across to E 551, since the tested materials are dif-
ferent from E 551, and the influence of the dye on stabil-
ity, distribution, and toxicity are not sufficiently known. 
Liver fibrosis could be induced after intravenous injection 
2904 Arch Toxicol (2016) 90:2885–2916
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of amorphous silica particles (though colloidal, and not E 
551) at doses of 50 mg/kg bw or even higher. Such expo-
sures have been shown to activate Kupffer cells with an 
increase in inflammatory markers and subtle biochemi-
cal changes, including a slight increase in AST in mice, 
minor to moderate histopathological changes, and inflam-
matory liver granulomas in rats (Chen et al. 2013; Downs 
et al. 2012). Liver granulomas containing resident (Kupffer 
cells) and recruited macrophages and lymphocytes were 
also found after intravenous injection of pyrogenic SAS at 
7 mg/kg, but there were no changes in biochemical serum 
marker. This finding was attributed to particle clearance 
mechanisms including uptake by macrophages and lyso-
somal degradation (Ivanov et al. 2012). However, systemic 
exposure levels, and hence also liver tissue exposure levels, 
that can be achieved by intravenous bolus injection cannot 
be reached after oral intake or gavage. There is therefore no 
basis for the assumption of a macrophage-induced liver re-
modelling and fibrosis after oral exposure, a pathway that 
theoretically might be possible, see, for example, (Ju and 
Tacke 2016).
In none of the several other available studies, includ-
ing an ongoing 90-day study with pyrogenic SAS in the 
low-dose range (NANoREG 2015), was any sign of liver 
fibrosis seen, nor any biochemical changes relating to liver 
toxicity found. To derive effect levels or calculating bench-
mark doses for E 551 based on the reported liver fibrosis in 
a single study (Jacobs et al. 2015) is therefore not justified.
In none of the available in vivo studies was there any 
adverse local effect on the gastrointestinal tract reported. 
Small but significant increase in villus heights and crypt 
depths in the jejunum, but no significant differences in the 
ratio between the villus height and crypt depth were found 
by van der Zande et al. (van der Zande et al. 2014). Accord-
ing to the study authors, long villi and a high villus:crypt 
ratio indicate a highly differentiated and active tissue. Gene 
set enrichment analysis on microarray data of jejunal epi-
thelial samples from either the 28 or 84 days of exposure 
to both SAS and NM-202 did not show differences in gene 
expression profiles between the treatment groups and the 
controls. This finding is therefore not considered to be 
adverse.
It has previously been hypothesised that accumulation 
of non-degradable particles in human Peyer’s patch mac-
rophages could exacerbate inflammation in Crohn’s dis-
ease (CD), but this could not be confirmed in human stud-
ies (Lomer et al. 2004). In work published in the form of a 
doctoral thesis, a silica-enriched diet containing 0.1 % SAS 
(which was not a product with the specifications of E 551) 
exacerbated the symptoms of irritable bowel disease (IBD) 
and enhanced mucosal inflammation in murine models of 
colitis (HA-VILLIN, DSS-induced acute and chronic coli-
tis). SAS had no effects in healthy mice used as controls. 
Oxidative DNA damage was even decreased in the colon 
tissue of colitis-induced mice and of healthy mice treated 
with the SAS-enriched diet when compared to controls 
(Winter 2010). An upregulation of MHC-II, CD80, and 
CD86 on dendritic cells (DC) was found in vitro, and pro-
inflammatory IL-beta was increased in endotoxin-activated 
DCs (Winter et al. 2011). In view of the absence in ani-
mal studies of any effects indicating immunotoxicity, and 
given that silicon dioxide particles are amongst the most 
abundant substances in the environment, including vegeta-
ble foods and the fact that the mucosa of the gastrointes-
tinal tract is therefore continuously exposed, it is unlikely 
that gut-associated lymphoid tissue and immunity could 
be adversely affected by the presence of silicon dioxide as 
used for E 551.
In vitro, neither pyrogenic nor precipitated silica affected 
the cell barrier integrity in Caco-2 intestinal cells, even 
after long-term exposure (7–21 days); with both pyrogenic 
and precipitated silica cytotoxic and cytostatic effects were 
registered only at very high concentrations (≥100 mg/L in 
human gastric epithelial cells (GES-1) and Caco-2 cells) 
(Contado et al. 2016; Farcal et al. 2015; Yang et al. 2014). 
In liver cells, GSH depletion and oxidative stress have been 
found only at very high test concentrations (≥200 mg/L), 
or long incubation times (25 mg/L for 72 h); aspartate ami-
notransferase in buffalo rat liver cells incubated with super-
natant from SiO2-stimulated Kupffer cells (resident hepatic 
macrophages) was only increased at ≥400 mg SiO2/L 
(Chen et al. 2013). Overall, these results do not demonstrate 
a particular sensitivity of the gastrointestinal tract or the 
liver towards silica particles. A reported “brush border dis-
ruption” in Caco-2 cells (Yang et al. 2016) after treatment 
with food-grade silica at concentrations of 0.01, 0.1, and 
1 mg/L for 24 h is not considered to be of relevance for the 
in vivo situation where the mucus layer is the major barrier 
for absorption (Fröhlich and Roblegg 2012). Furthermore, 
no adverse local effects on the gastrointestinal mucosa have 
been found in any of the animal studies. In some in vitro 
experiments with murine macrophages, pyrogenic silica 
showed effects at lower concentrations than precipitated sil-
ica (Di Cristo et al. 2016; Gazzano et al. 2012; Zhang et al. 
2012), while there were no significant differences in other 
cell types, including Caco-2 intestinal or testicular cells 
(Farcal et al. 2012). The difference tentatively has been 
ascribed to the complete coverage of precipitated silica 
with water which would protect the cells from any effect 
caused by direct contact between particle surface and cell 
membrane. From further experiments it appears that also a 
complete dehydroxylation would reduce silica surface reac-
tivity. Any intermediate situation would be more reactive 
due to the complex interplay between cell membrane and 
particle surface (Gazzano et al. 2012). Zhang et al. (2012) 
see the main factor in an energetic unstable condition with 
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radical formation on the surface of pyrogenic silica. [It is 
noted that Gazzano et al. did not find evidence of radical 
formation, neither on the surface of pyrogenic nor that of 
precipitated silica using electron paramagnetic resonance 
(EPR)/electron spin resonance (ESR), a suitable method for 
silica nanomaterials according to an OECD review (OECD 
2016)]. Information from in vitro studies with regard to cel-
lular uptake in macrophages is contradictory: in one study 
it is reported that pyrogenic silica is more efficiently taken 
up when compared with precipitated silica (Di Cristo et al. 
2016); in another study this was not the case (Zhang et al. 
2012). Others hypothesise that differences in agglomera-
tion state and solubility are responsible for different bio-
logical effects in vitro (Aureli et al. 2012), but there is also 
evidence to the contrary (Di Cristo et al. 2016; Rabolli 
et al. 2011). Slight increases in pro-inflammatory cytokines 
(but no overt toxicity) were observed at ≥5 µg/cm2 in 
murine macrophages (cf Table 6) . Apart from the fact that 
the relevance of this in vitro murine model is questionable 
with regard to humans, see, for example, (Erbel et al. 2013; 
Mestas and Hughes 2004), the exposure levels were unreal-
istically high. Even under the assumption of direct contact 
with the intestinal epithelium (which in fact is protected by 
a mucous layer and is composed of different cell types) and 
an intake of up to 1500 mg/day (EFSA 2009), the amount 
of E 551 in the intestinal lumen would not reach an in vitro 
effective dose level (taking into account that the mean 
total mucosal surface of the digestive tract interior aver-
ages 32 m2 (Helander and Fandriks 2014), up to 4.6 µg/cm2 
could theoretically be estimated for the intestinal lumen). 
The described differences in vitro are therefore not relevant 
for the in vivo situation after oral exposure to E 551. This is 
supported by the lack of effects in oral animal studies.
Conclusion
The systemic availability of E 551 is very low. There is no 
evidence for the release of nanosized particles in the stom-
ach, but some dissolution and formation of orthosilicic acid 
may occur in the lower intestinal tract. None of the tested 
E 551 products caused any adverse local or systemic effect 
in oral repeated-dose, fertility, and developmental toxic-
ity studies. In particular, there were no signs indicative of 
liver toxicity or macrophage-induced liver re-modelling 
even at very high oral doses. There were also no indica-
tions of immunotoxicity or neurotoxicity. Reported effects 
after low-dose exposure to pyrogenic SAS are all within 
the normal physiological range and cannot be considered 
as adverse. SAS was not mutagenic or genotoxic in vivo. In 
intact cells, a direct interaction of unlabelled and unmodi-
fied SAS with DNA was never found. Differences in the 
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precipitated silica described in some in vitro studies with 
murine macrophages at exaggerated exposures seem to be 
related to interactions with cell culture proteins and cell 
membranes. The available toxicological evidence in vivo 
shows that there is no difference in the toxicity of E 551 
products, independent of their manufacturing method. 
Based on the available evidence, it is concluded that silicon 
dioxide used as a food additive (E 551) is a substance of 
very low toxicity which based on the total dietary intake 
(from its use as a food additive, and its use in dietary sup-
plements) does not represent a human health risk. Any new 
or novel forms of silicon dioxide that do not comply with 
established specifications, or are produced to perform a 
new technological function in food, would require specific 
safety and risk assessments.
Acknowledgments The preparation of this manuscript was finan-
cially supported by the Association of Amorphous Silica Producers 
(ASASP).
References
Agir pour l’environnement (2016) Enquête inédite révélant la 
présence de nanoparticules cachées dans l’alimentation: les 
pouvoirs publics doivent protéger les consommateurs! Commu-
niqué de presse du 15 juin
Ahmad J, Ahamed M, Akhtar MJ et al (2012) Apoptosis induction 
by silica nanoparticles mediated through reactive oxygen spe-
cies in human liver cell line HepG2. Toxicol Appl Pharmacol 
259(2):160–168. doi:10.1016/j.taap.2011.12.020
Albers P, Maier M, Reisinger M, Hannebauer B, Weinand R (2015) 
Physical boundaries within aggregates—differences between 
amorphous, para-crystalline, and crystalline structures. Cryst 
Res Technol 50:846–865. doi:10.1002/crat.201500040
Amenta V et al (2015) Regulatory aspects of nanotechnology in the 
agri/feed/food sector in EU and non-EU countries. Regul Toxi-
col Pharmacol 73:463–476. doi:10.1016/j.yrtph.2015.06.016
Aureli F, D’Amato M, De Berardis B, Raggi A, Turco AC, Cubadda 
F (2012) Investigating agglomeration and dissolution of silica 
nanoparticles in aqueous suspensions by dynamic reaction cell 
inductively coupled plasma-mass spectrometry in time resolved 
mode. J Anal At Spectrom 27:1540–1548
Babick F, Mielke J, Wohlleben W, Weigel S, Hodoroaba V-D (2016) 
How reliably can a material be classified as a nanomaterial? 
Available particle-sizing techniques at work. J Nanopart Res 
18:1–40. doi:10.1007/s11051-016-3461-7
Barahona F, Ojea-Jimenez I, Geiss O, Gilliland D, Barrero-Moreno J 
(2016) Multimethod approach for the detection and characteri-
sation of food-grade synthetic amorphous silica nanoparticles. J 
Chromatogr A 1432:92–100. doi:10.1016/j.chroma.2015.12.058
Barnes CA, Elsaesser A, Arkusz J et al (2008) Reproducible comet 
assay of amorphous silica nanoparticles detects no genotoxicity. 
Nano Lett 8(9):3069–3074. doi:10.1021/nl801661w
Brunner TJ, Wick P, Manser P et al (2006) In vitro cytotoxic-
ity of oxide nanoparticles: comparison to asbestos, silica, 
and the effect of particle solubility. Environ Sci Technol 
40(14):4374–4381
Buesen R, Landsiedel R, Sauer UG et al (2014) Effects of SiO2, 
ZrO2, and BaSO4 nanomaterials with or without surface 
functionalization upon 28-day oral exposure to rats. Arch Toxi-
col 88(10):1881–1906. doi:10.1007/s00204-014-1337-0
Casey TR, Bamforth CW (2010) Silicon in beer and brewing. J Sci 
Food Agric 90(5):784–788. doi:10.1002/jsfa.3884
CEFIC (2011) 28-day oral toxicity study of synthetic amorphous sil-
ica in Wistar (WU) rats. CEFIC Brussels/Belgium
CEFIC (2012a) In vitro mammalian cell gene mutation test in mouse 
lymphoma L5178Y/TK ± Cells with synthetic amorphous sil-
ica (NM-200). CEFIC Brussels/Belgium
CEFIC (2012b) In vitro mammalian chromosome aberration test 
(V79 Cells) with synthetic amorphous silica (NM-200). CEFIC 
Brussels/Belgium
CEFIC (2012c) Measurement of the DNA-damaging and cytotoxic 
potential of synthetic amorphous silica (NM-200) in cultured 
primary rat alveolar macrophages. CEFIC Brussels, Belgium
Cha KE, Myung H (2007) Cytotoxic effects of nanoparticles assessed 
in vitro and in vivo. J Microbiol Biotechnol 17(9):1573–1578
Chang J-S, Chang KLB, Hwang D-F, Kong Z-L (2007) In vitro cyto-
toxicitiy of silica nanoparticles at high concentrations strongly 
depends on the metabolic activity type of the cell line. Environ 
Sci Technol 41(6):2064–2068. doi:10.1021/es062347t
Chen Q, Xue Y, Sun J (2013) Kupffer cell-mediated hepatic injury 
induced by silica nanoparticles in vitro and in vivo. Int J 
Nanomed 8:1129–1140. doi:10.2147/IJN.S42242
Contado C, Mejia J, Lozano Garcia O, Piret JP, Dumortier E, Tous-
saint O, Lucas S (2016) Physicochemical and toxicological 
evaluation of silica nanoparticles suitable for food and con-
sumer products collected by following the EC recommen-
dation. Anal Bioanal Chem 408(1):271–286. doi:10.1007/
s00216-015-9101-8
De Jong WH (2012) NANOGENOTOX—Stakeholders workshop:3 
May, 2012—Brussels
Decan N, Wu D, Williams A et al (2016) Characterization of in vitro 
genotoxic, cytotoxic and transcriptomic responses following 
exposures to amorphous silica of different sizes. Mutat Res/
Genet Toxicol Environ Mutagen 796:8–22. doi:10.1016/j.
mrgentox.2015.11.011
Dekkers S et al (2011) Presence and risks of nanosilica in food prod-
ucts. Nanotoxicology 5:393–405
Demir E, Aksakal S, Turna F, Kaya B, Marcos R (2015) In vivo geno-
toxic effects of four different nano-sizes forms of silica nano-
particles in Drosophila melanogaster. J Hazard Mater 283:260–
266. doi:10.1016/j.jhazmat.2014.09.029
Di Cristo L et al (2016) Proinflammatory effects of pyrogenic and 
precipitated amorphous silica nanoparticles in innate immunity 
cells. Toxicol Sci 150:40–53. doi:10.1093/toxsci/kfv258
Di Felice G et al (2016) In vivo and in vitro immunotoxicity of SiO2 
nanoparticles. Abstract. 8th International Nanotoxicology Con-
gress. Boston, USA
Downs TR et al (2012) Silica nanoparticles administered at the maxi-
mum tolerated dose induce genotoxic effects through an inflam-
matory reaction while gold nanoparticles do not. Mutat Res 
745:38–50. doi:10.1016/j.mrgentox.2012.03.012
Drescher D, Orts-Gil G, Laube G, et al (2011) Toxicity of amorphous 
silica nanoparticles on eukaryotic cell model is determined by 
particle agglomeration and serum protein adsorption effects. 
Anal Bioanal Chem 400:1367–1373
Duan J, Yu Y, Li Y et al (2013) Toxic effect of silica nanoparti-
cles on endothelial cells through DNA damage response via 
Chk1-dependent G2/M checkpoint. PLoS One 8(4):e62087. 
doi:10.1371/journal.pone.0062087
Dünisch (2005) Untersuchungen der Wirkungsweise von Nanomateri-
alien. Dissertation. Universität Würzburg
Dusinska M, Tran L (2015) NanoTEST in a nutshell. Nanotoxicology 
9(Suppl 1):1–4. doi:10.3109/17435390.2014.991774
2913Arch Toxicol (2016) 90:2885–2916 
1 3
EC (2007) European Commission. Best available techniques refer-
ence document (BREF). Integrated pollution prevention and 
control. Reference document on best available techniques for 
the manufacture of large volume inorganic chemicals–solids 
and others industry. Chapter 5: synthetic amorphous silica. 
August 2007
ECETOC (2006) European centre for ecotoxicology and toxicology 
of chemicals. JACC No. 51 “Synthetic amorphous silica (CAS 
No. 7631-86-9)”, Brussels, Belgium
EFSA (2004) European Food Safety Authority. Opinion of the sci-
entific panel on dietetic products, nutrition and allergies on a 
request from the commission related to the tolerable upper 
intake level of silicon
EFSA (2009) European Food Safety Authority. Calcium silicate 
and silicon dioxide/silicic acid gel added for nutritional pur-
poses to food supplements. EFSA J 7:n/a–n/a. doi:10.2903/j.
efsa.2009.1132
EFSA (2012) European Food Safety Authority (EFSA) Panel on 
food additives and nutrient sources added to food (ANS); guid-
ance for submission for food additive evaluations. EFSA J 
10(7):2760. doi:10.2903/j.efsa.2012.2760. www.efsa.europa.eu/
efsajournal
Erbel C, Rupp G, Helmes CM, Tyka M, Linden F, Doesch AO et al 
(2013) An in vitro model to study heterogeneity of human mac-
rophage differentiation and polarization. J Vis Exp 76:e50332. 
doi:10.3791/50332
Farcal LR et al (2012) Mechanisms of toxicity induced by SiO(2) nano-
particles of in vitro human alveolar barrier: effects on cytokine 
production, oxidative stress induction, surfactant proteins A 
mRNA expression and nanoparticles uptake. Nanotoxicology. doi
:10.3109/17435390.2012.710658
Farcal L et al (2015) Comprehensive in vitro toxicity testing of a 
panel of representative oxide nanomaterials: first steps towards 
an intelligent testing strategy. PLoS ONE 10:e0127174. 
doi:10.1371/journal.pone.0127174
FCRA (2016) Estimation of dietary intakes of Silicon Dioxide (E551) 
from use as a food additive in Europe. Report provided for 
Evonik Industries AG. 18th June 2016
Fessard V et al (2016) In Vivo Genotoxicity of SiO2 Nanoparticle 
after Sub-chronic Oral Exposure. Abstract. 8th International 
Nanotoxicology Congress. Boston, USA
Fröhlich E, Roblegg E (2012) Models for oral uptake of nanoparticles 
in consumer products. Toxicology 291:10–17. doi:10.1016/j.
tox.2011.11.004
Fruijtier-Pölloth C (2012) The toxicological mode of action 
and the safety of synthetic amorphous silica-a nanostruc-
tured material. Toxicology 294:61–79. doi:10.1016/j.
tox.2012.02.001
Gazzano E et al (2012) Physicochemical determinants in the cellular 
responses to nanostructured amorphous silicas. Toxicol Sci Off 
J Soc Toxicol 128:158–170. doi:10.1093/toxsci/kfs128
Gehrke H, Frühmesser A, Pelka J et al (2013) In vitro toxicity of 
amorphous silica nanoparticles in human colon carcinoma cells. 
Nanotoxicology 7(3):274–293. doi:10.3109/17435390.2011.65
2207
Gerloff K, Albrecht C, Boots AW, Förster I, Schins RPF (2009) 
Cytotoxicity and oxidative DNA damage by nanoparticles in 
human intestinal Caco-2 cells. Nanotoxicology 3(4):355–364. 
doi:10.3109/17435390903276933
Gerloff K (2010) Nanoparticles and the Intestine. Thesis. Heinrich 
Heine Universität Düsseldorf, Germany
Gerloff K, Pereira DIA, Faria N et al (2013) Influence of simulated 
gastro-intestinal conditions on particle-induced cytotoxicity and 
interleukin-8 regulation in differentiated and undifferentiated 
Caco-2 cells. Nanotoxicology 7:353–366. doi:10.3109/174353
90.2012.662249
Gonzalez L, Thomassen LC, Plas G et al (2010) Exploring the aneu-
genic and clastogenic potential in the nanosize range: A549 
human lung carcinoma cells and amorphous monodisperse silica 
nanoparticles as models. Nanotoxicology 4:382–395. doi:10.310
9/17435390.2010.501913
Gonzalez L, Lukamowicz-Rajska M, Thomassen LCJ et al (2014) Co-
assessment of cell cycle and micronucleus frequencies demon-
strates the influence of serum on the in vitro genotoxic response 
to amorphous monodisperse silica nanoparticles of varying 
sizes. Nanotoxicology 8(8):876–884. doi:10.3109/17435390.2
013.842266
Gray CA, Muranko H (2006) Studies of robustness of industrial acini-
form aggregates and agglomerates–carbon black and amorphous 
silicas: a review amplified by new data. J Occup Environ Med/
Am Coll Occup Environ Med 48:1279–1290. doi:10.1097/01.
jom.0000251477.40643.2a
Guichard Y et al (2015) Genotoxicity of synthetic amorphous silica 
nanoparticles in rats following short-term exposure. Part 2: 
intratracheal instillation and intravenous injection. Environ Mol 
Mutagen 56:228–244. doi:10.1002/em.21928
Helander HF, Fandriks L (2014) Surface area of the digestive tract—
revisited. Scand J Gastroenterol 49:681–689. doi:10.3109/0036
5521.2014.898326
Hofmann T, Schneider S, Wolterbeek A, van de Sandt H, Landsie-
del R, van Ravenzwaay B (2015) Prenatal toxicity of synthetic 
amorphous silica nanomaterial in rats. Reprod Toxicol 56:141–
146. doi:10.1016/j.reprotox.2015.04.006
Howe SE, Lickteig DJ, Plunkett KN, Ryerse JS, Konjufca V (2014) 
The uptake of soluble and particulate antigens by epithe-
lial cells in the mouse small intestine. PLoS ONE 9:e86656. 
doi:10.1371/journal.pone.0086656
IARC (1997) International agency for research on cancer. Mono-
graphs on the evaluation of carcinogenic risks to humans, Vol 
68. Silica. Summary of data reported and evaluation- World 
Health Organization
Inlivetox (2012) Toxicity of ingested nanoparticles. Development and 
evaluation of a novel tool for physiologically accurate data gen-
eration. EU 7th framework programme report CP-FP 228625-2. 
Final Publishable Summary Report
Ivanov S, Zhuravsky S, Yukina G, Tomson V, Korolev D, Galagudza 
M (2012) In vivo toxicity of intravenously administered silica 
and silicon nanoparticles. Materials 5:1873–1889
Jacobs R, van der Voet H, ter Braak CJF (2015) Integrated probabil-
istic risk assessment for nanoparticles: the case of nanosilica in 
food. J Nanopart Res 17:1–14. doi:10.1007/s11051-015-2911-y
Johnston CJ, Driscoll KE, Finkelstein JN et al (2000) Pulmonary 
chemokine and mutagenic responses in rats after subchronic 
inhalation of amorphous and crystalline silica. Toxicol Sci 
56(2):405–413
JRC (2013) European Commission Joint Research Centre Scientific 
and Policy Reports. Synthetic Amorphous Silicon Dioxide 
(NM-200, NM-201, NM-202, NM-203, NM-204): Characteri-
sation and physico-chemical properties. JRC repository: NM-
series of representative manufactured nanomaterials. Publica-
tions Office of the European Union, Luxembourg
Ju C, Tacke F (2016) Hepatic macrophages in homeostasis and liver 
diseases: from pathogenesis to novel therapeutic strategies. Cell 
Mol Immunol 13:316–327. doi:10.1038/cmi.2015.104
Jugdaohsingh R (2007) Silicon and bone health. J Nutr Health Aging 
11:99–110
Jugdaohsingh R, Watson AI, Bhattacharya P, van Lenthe GH, 
Powell JJ (2015) Positive association between serum sili-
con levels and bone mineral density in female rats follow-
ing oral silicon supplementation with monomethylsilanetriol. 
Osteoporos int: a journal established as result of cooperation 
between the European Foundation for Osteoporosis and the 
2914 Arch Toxicol (2016) 90:2885–2916
1 3
National Osteoporosis Foundation of the USA 26:1405–1415. 
doi:10.1007/s00198-014-3016-7
Jurkić LM, Cepanec I, Pavelić SK, Pavelić K (2013) Biological and 
therapeutic effects of ortho-silicic acid and some ortho-silicic 
acid-releasing compounds: new perspectives for therapy. Nutr 
Metab 10:2–2. doi:10.1186/1743-7075-10-2
Kim HW, Ahn E-K, Jee BK, Yoon H-K, Lee KH, Lim Y (2009) 
Nanoparticulate-induced toxicity and related mecha-
nism in vitro and in vivo. J Nanopart Res 11(1):55–65. 
doi:10.1007/s11051-008-9447-3
Kim Y-J, Yu M, Park H-O, Yang S (2010) Comparative study of 
cytotoxicity, oxidative stress and genotoxicity induced by sil-
ica nanomaterials in human neuronal cell line. Mol Cell Toxi-
col 6(4):336–343. doi:10.1007/s13273-010-0045-y
Kim YR, Lee SY, Lee EJ et al (2014) Toxicity of colloidal silica 
nanoparticles administered orally for 90 days in rats. Int J 
Nanomedicine 9(Suppl 2):67–78. doi:10.2147/ijn.s57925
Kim I-Y, Joachim E, Choi H, Kim K (2015) Toxicity of silica 
nanoparticles depends on size, dose, and cell type. Nanomed 
Nanotechnol Biol Med 11(6):1407–1416. doi:10.1016/j.
nano.2015.03.004
Klosterkoetter W (1969) Gewerbehygienisches Gutachten ueber die 
hochdisperse Kieselsaeure "HDK V 15". Unpublished report 
for Wacker-Chemie. Institut für Hygiene und Arbeitsmedizin
Knebel J, Ziemann C, Creutzenberg OH (2014) CEFIC-LRI N1 
Project: Genotoxicity of a synthetic amorphous silica (SAS) 
in rats. Abstract #601, The toxicologist
Kwon JY, Kim HL, Lee JY et al (2014) Undetactable levels of geno-
toxicity of SiO(2) nanoparticles in in vitro and in vivo tests. Int 
J Nanomed 9(Suppl 2):173–181. doi:10.2147/IJN.S57933
Kurfeβ D, Hinrichsen H, Zimmermann I (2005) Statistical model of 
the powder flow regulation by nanomaterials. Powder Technol 
159:63–70. doi:10.1016/j.powtec.2005.06.004
Linsinger T, Roebben G, Gilliland D, Calzolai L, Rossi F, Gibson N, 
Klein C (2012) Requirements on measurements for the imple-
mentation of the European Commission definition of the term 
“nanomaterial”. JRC Reference Reports, European Commission 
Joint Research Centre
Liu X, Keane MJ, Zhong BZ, Ong TM, Wallace WE (1996) Micronu-
cleus formation in V79 cells treated with respirable silica dis-
persed in medium and in simulated pulmonary surfactant. Mutat 
Res 361(2–3):89–94
Lomer MC, Hutchinson C, Volkert S, Greenfield SM, Catterall A, 
Thompson RP, Powell JJ (2004) Dietary sources of inorganic 
microparticles and their intake in healthy subjects and patients 
with Crohn’s disease. Br J Nutr 92:947–955
Lu X, Qian J, Zhou H et al (2011) In vitro cytotoxicity and induction 
of apoptosis by silica nanoparticles in human HepG2 hepatoma 
cells. Int J Nanomed 6:1889–1901. doi:10.2147/ijn.s24005
Ma-Hock L et al (2007) Generation and characterization of test 
atmospheres with nanomaterials. Inhal toxicol 19:833–848. 
doi:10.1080/08958370701479190
Maier M, Hannebauer B, Holldorff H, Albers P (2006) Does lung 
surfactant promote disaggregation of nanostructured titanium 
dioxide? J Occup Environ Med/Am Coll Occup Environ Med 
48:1314–1320. doi:10.1097/01.jom.0000215405.72714.b2
Maier M, Babick F, Retamal Marin R, Stintz M (2013) Does nano-
structured synthetic amorphous silica´disintegrate after oral 
uptake? Abstract #1754. The Toxicologist
Maranghi F, Narciso L, Tait S, Martinelli A, Di Virgilio A, Valeri M, 
Tassinari R (2016) 90-day repeated dose oral toxicity study on 
synthetic amorphous silica NM 203: the EFSA approach. Poster. 
8th International Nanotoxicology Congress. Boston, USA
Maser E, Schulz M, Sauer UG et al (2015) In vitro and in vivo geno-
toxicity investigations of differently sized amorphous SiO2 
nanomaterials. Mutat Res/Genet Toxicol Environ Mutagen 
794:57–74. doi:10.1016/j.mrgentox.2015.10.005
McCracken C (2015) Toxicity of food-relevant nanoparticles in intes-
tinal epithelial models. Dissertation presented in partial fulfill-
ment of the requirements for the degree doctor of Philosophy in 
the graduate school of The Ohio State University
McCracken C, Zane A, Knight DA, Dutta PK, Waldman WJ (2013) 
Minimal intestinal epithelial cell toxicity in response to short- 
and long-term food-relevant inorganic nanoparticle exposure. 
Chem Res Toxicol 26(10):1514–1525. doi:10.1021/tx400231u
McCracken C, Dutta PK, Waldman WJ (2016) Critical assessment 
of toxicological effects of ingested nanoparticles. Environ Sci 
Nano 3(2):256–282. doi:10.1039/C5EN00242G
Mendoza A, Torres-Hernandez JA, Ault JG, Pedersen-Lane JH, Gao 
D, Lawrence DA (2014) Silica nanoparticles induce oxidative 
stress and inflammation of human peripheral blood mononu-
clear cells. Cell Stress Chaperones 19(6):777–790. doi:10.1007/
s12192-014-0502-y
Mestas J, Hughes CCW (2004) Of mice and not men: differences 
between mouse and human immunology. J Immunol 172:2731–
2738. doi:10.4049/jimmunol.172.5.2731
Mu Q, Hondow NS, Krzemin´ski Ł, Brown AP, Jeuken LJ, Rout-
ledge MN (2012) Mechanism of cellular uptake of geno-
toxic silica nanoparticles. Part Fibre Toxicol 9(1):1–11. 
doi:10.1186/1743-8977-9-29
Müller A-K, Ruppel J, Drexel C-P, Zimmermann I (2008) Precipi-
tated silica as flow regulator. Eur J Pharm Sci 34:303–308. 
doi:10.1016/j.ejps.2008.05.003
NANOGENOTOX (2013) Facilitating the safety evaluation of manu-
factured nanomaterials by characterising their potential geno-
toxic hazard. Final publishable report. March 2013. http://www.
nanogenotox.eu/
NANoREG (2015) WP 4.5—90d toxiciy study in rats. As presented 
at the 2015 Annual Congress of the European Environmental 
Mutagenesis and Genomics Society and at NanoItaly
Napierska D, Thomassen LC, Rabolli V et al (2009) Size-depend-
ent cytotoxicity of monodisperse silica nanoparticles in 
human endothelial cells. Small 5(7):846–853. doi:10.1002/
smll.200800461
OECD (2004) Screening information data set (SIDS). Synthetic 
Amorphous Silica and Silicates. Paris
OECD (2016) Organisation for Economic Co-operation and Devel-
opment. Physical-chemical properties of nanomaterials: Evalu-
ation of methods applied in the OECD-WPMN testing pro-
gramme. ENV/JM/MONO(2016)7
Pandurangi RS, Seehra MS, Razzaboni BL, Bolsaitis P (1990) Surface 
and bulk infrared modes of crystalline and amorphous silica 
particles: a study of the relation of surface structure to cytotox-
icity of respirable silica. Environ Health Perspect 86:327–336
Park EJ, Park K (2009) Oxidative stress and pro-inflammatory 
responses induced by silica nanoparticles in vivo and in vitro. 
Toxicol Lett 184(1):18–25. doi:10.1016/j.toxlet.2008.10.012
Park MV et al (2009) In vitro developmental toxicity test detects 
inhibition of stem cell differentiation by silica nanoparti-
cles. Toxicol Appl Pharmacol 240:108–116. doi:10.1016/j.
taap.2009.07.019
Park MV, Verharen HW, Zwart E et al (2011) Genotoxicity evaluation 
of amorphous silica nanoparticles of different sizes using the 
micronucleus and the plasmid lacZ gene mutation assay. Nano-
toxicology 5(2):168–181. doi:10.3109/17435390.2010.506016
Peters R et al (2012) Presence of nano-sized silica during in vitro 
digestion of foods containing silica as a food additive. ACS 
Nano 6:2441–2451. doi:10.1021/nn204728k
Poulsen MS, Mose T, Maroun LL, Mathiesen L, Knudsen LE, Rytting 
E (2015) Kinetics of silica nanoparticles in the human placenta. 
2915Arch Toxicol (2016) 90:2885–2916 
1 3
Nanotoxicology 9(Suppl 1):79–86. doi:10.3109/17435390.2013.
812259
Powell JJ et al (2005) A provisional database for the silicon content of 
foods in the United Kingdom. Br J Nutr 94:804–812
Robberecht H, Van Cauwenbergh R, Van Vlaslaer V, Hermans N 
(2009) Dietary silicon intake in Belgium: sources, avail-
ability from foods, and human serum levels. Sci Total Environ 
407(16):4777–4782. doi:10.1016/j.scitotenv.2009.05.019
Rabolli V, Thomassen LC, Uwambayinema F, Martens JA, Lison D 
(2011) The cytotoxic activity of amorphous silica nanoparticles 
is mainly influenced by surface area and not by aggregation. 
Toxicol Lett 206:197–203. doi:10.1016/j.toxlet.2011.07.013
Ruppel J, Müller A-K, Althaus G, Drexel C-P, Zimmermann I 
(2009) The modified outflow funnel — A device to assess the 
flow characteristics of powders. Powder Technol 193:87–92. 
doi:10.1016/j.powtec.2009.02.011
Sakai-Kato K, Hidaka M, Un K, Kawanishi T, Okuda H (2014) Phys-
icochemical properties and in vitro intestinal permeability prop-
erties and intestinal cell toxicity of silica particles, performed in 
simulated gastrointestinal fluids. Biochimica et Biophysica Acta 
(BBA)—General Subjects 1840:1171–1180. doi:10.1016/j.
bbagen.2013.12.014
Sayes CM, Reed KL, Warheit DB (2007) Assessing toxicity of fine 
and nanoparticles: comparing in vitro measurements to in vivo 
pulmonary toxicity profiles. Toxicol Sci 97(1):163–180. 
doi:10.1093/toxsci/kfm018
Sayes CM, Reed KL, Glover KP et al (2010) Changing the dose met-
ric for inhalation toxicity studies: short-term study in rats with 
engineered aerosolized amorphous silica nanoparticles. Inhala-
tion Toxicol 22(4):348–354. doi:10.3109/08958370903359992
SCCS (2015) EU Scientific Committee on Consumer Safety. Opin-
ion on Silica, Hydrated Silica, and Silica Surface Modified with 
Alkyl Silylates (nano form) 20 March 2015, SCCS/1545/15, 
revision of 29 September
Schneider S, Landsiedel R, Wohlleben W, Wolterbeek A, Waalkens-
Berendsen I, van de Sandt H (2011) Oral prenatal develop-
mental toxicity study with NM-200 synthetic amorphous silica 
in Wistar rats. Reprod Toxicol 32:173–174. doi:10.1016/j.
reprotox.2011.06.102
Sergent JA, Paget V, Chevillard S (2012) Toxicity and genotoxicity of 
nano-SiO2 on human epithelial intestinal HT-29 cell line. Ann 
Occup Hyg 56(5):622–630. doi:10.1093/annhyg/mes005
Setyawati MI, Tay CY, Leong DT (2015) Mechanistic investigation 
of the biological effects of SiO2, TiO2, and ZnO nanoparti-
cles on intestinal cells. Small 11(28):3458–3468. doi:10.1002/
smll.201403232
Shumakova AA, Arianova EA, Shipelin VA et al (2014a) Toxico-
logical assessment of nanostructured silica. I. Integral indices, 
adducts of DNA, tissue thiols and apoptosis in liver. Vopr Pitan 
83(3):52–62
Shumakova AA, Avrent’eva LI, Guseva GV et al (2014b) Toxico-
logical assessment of nanostructured silica. II. Enzymatic, 
biochemical indices, state of antioxidative defence. Vopr Pitan 
83(4):58–66
Shumakova AA, Efimochkina NR, Minaeva LP et al (2015) Toxi-
cological assessment of nanostructured silica. III. Microeco-
logical, hematological indices, state of cellular immunity. Vopr 
Pitan 84(4):55–65
Singh G, Stephan C, Westerhoff P, Carlander D, Duncan TV (2014) 
Measurement methods to detect, characterize, and quantify 
engineered nanomaterials in food. Compr Rev Food Sci Food 
Saf 13:693–704
Slowing II, Wu CW, Vivero-Escoto JL, Lin VS (2009) Mesoporous 
silica nanoparticles for reducing hemolytic activity towards 
mammalian red blood cells. Small 5(1):57–62. doi:10.1002/
smll.200800926
Takizawa Y, Hirasama F, Noritomi E, Aida M, Tsunoda H, 
Uesugi S (1988) Oral ingestion of syloid to mice and rats 
and its chronic toxicity and carcinogenicity. Acta Med Biol 
36:27–56
Tarantini A et al (2015a) Genotoxicity of synthetic amorphous silica 
nanoparticles in rats following short-term exposure. Part 1: 
oral route. Environ Mol Mutagen 56:218–227. doi:10.1002/
em.21935
Tarantini A et al (2015b) Toxicity, genotoxicity and proinflamma-
tory effects of amorphous nanosilica in the human intestinal 
Caco-2 cell line. Toxicol In Vitro 29:398–407. doi:10.1016/j.
tiv.2014.10.023
Tavares AM et al (2014) Genotoxicity evaluation of nanosized tita-
nium dioxide, synthetic amorphous silica and multi-walled car-
bon nanotubes in human lymphocytes. Toxicol In Vitro 28:60–
69. doi:10.1016/j.tiv.2013.06.009
Tay CY, Fang W, Setyawati MI et al (2013) Reciprocal response 
of human oral epithelial cells to internalized silica nanopar-
ticles. Part Part Syst Charact 30(9):784–793. doi:10.1002/
ppsc.201300111
Tennant DR (2016) Comprehensive European dietary exposure 
model (CEDEM) for food additives. Food Addit Contam Part 
A 33:772–781
Uboldi C, Giudetti G, Broggi F, Gilliland D, Ponti J, Rossi F 
(2012) Amorphous silica nanoparticles do not induce cyto-
toxicity, cell transformation or genotoxicity in Balb/3T3 
mouse fibroblasts. Mutat Res 745(1–2):11–20. doi:10.1016/j.
mrgentox.2011.10.010
van der Zande M et al (2014) Sub-chronic toxicity study in rats 
orally exposed to nanostructured silica. Part fibre toxicol 11:8. 
doi:10.1186/1743-8977-11-8
van Kesteren PC, Cubadda F, Bouwmeester H, van Eijkeren JC, Dek-
kers S, de Jong WH, Oomen AG (2015) Novel insights into the 
risk assessment of the nanomaterial synthetic amorphous silica, 
additive E551, in food. Nanotoxicology 9:442–452. doi:10.310
9/17435390.2014.940408
Wang F, Gao F, Lan M, Yuan H, Huang Y, Liu J (2009) Oxidative 
stress contributes to silica nanoparticle-induced cytotoxicity in 
human embryonic kidney cells. Toxicol In Vitro 23(5):808–815. 
doi:10.1016/j.tiv.2009.04.009
Winter M (2010) Immunstimulatorische und immunregulierende 
Wirkungen von Nanopartikeln und Umweltschadstoffen auf das 
Darm assoziierte Immunsystem. Inaugural Dissertation. Hein-
rich Heine Universität Düsseldorf
Winter M, Beer HD, Hornung V, Kramer U, Schins RP, Forster I 
(2011) Activation of the inflammasome by amorphous silica 
and TiO2 nanoparticles in murine dendritic cells. Nanotoxicol-
ogy 5:326–340. doi:10.3109/17435390.2010.506957
Wolterbeek A et al (2015) Oral two-generation reproduction tox-
icity study with NM-200 synthetic amorphous silica in 
Wistar rats. Reprod Toxicol 56:147–154. doi:10.1016/j.
reprotox.2015.03.006
Yamashita K et al (2011) Silica and titanium dioxide nanoparti-
cles cause pregnancy complications in mice. Nat Nanotechnol 
6:321–328. doi:10.1038/nnano.2011.41
Yang YX et al (2014) Evaluation of the toxicity of food additive sil-
ica nanoparticles on gastrointestinal cells. J appl toxicol JAT 
34:424–435. doi:10.1002/jat.2962
Yang Y, Faust JJ, Schoepf J, Hristovski K, Capco DG, Herckes P, 
Westerhoff P (2016) Survey of food-grade silica dioxide nano-
material occurrence, characterization, human gut impacts 
and fate across its lifecycle. Sci Total Environ. doi:10.1016/j.
scitotenv.2016.01.165
Ye Y, Liu J, Chen M, Sun L, Lan M (2010a) In vitro toxicity of silica 
nanoparticles in myocardial cells. Environ Toxicol Pharmacol 
29(2):131–137. doi:10.1016/j.etap.2009.12.002
2916 Arch Toxicol (2016) 90:2885–2916
1 3
Ye Y, Liu J, Xu J, Sun L, Chen M, Lan M (2010b) Nano-SiO2 induces 
apoptosis via activation of p53 and Bax mediated by oxidative 
stress in human hepatic cell line. Toxicol In Vitro 24(3):751–
758. doi:10.1016/j.tiv.2010.01.001
Yu T, Malugin A, Ghandehari H (2011) Impact of silica nanoparti-
cle design on cellular toxicity and hemolytic activity. ACS nano 
5(7):5717–5728. doi:10.1021/nn2013904
Zhang H et al (2012) Processing pathway dependence of amorphous 
silica nanoparticle toxicity: colloidal vs pyrolytic. J Am Chem 
Soc 134:15790–15804. doi:10.1021/ja304907c
Zhong BZ, Whong WZ, Ong TM (1997) Detection of mineral-dust-
induced DNA damage in two mammalian cell lines using the 
alkaline single cell gel/comet assay. Mutat Res 393(3):181–187
Zijno A, Palamides J, Andreoli C, De Berardis B, Barone F (2016) 
Genotoxicity Assessment of Silica and Titania on BEAS-2B 
Cells in the Framework of the EU NANoREG Project. Abstract. 
8th International Nanotoxicology Congress. Boston, USA
